Gene Therapy Innovation and Manufacturing Centre (GTIMC) is pleased to announce its attendance at the British Society for Gene and Cell Therapy Annual Conference 2026 in Newcastle 15th - 17th April.
Members of our team attending will be:
Prof Mimoun Azzouz, Director GTIMC
Prof Guillaume Hautbergue, Skills and Training Deputy Lead
Dr Joe Cartwright, Head of Projects
Dr Rebecca Andrew, Business Development Manager
Mimoun will present "From Discovery to Translation: A Journey Towards New Era of Molecular Healing" in the Opening Plenary session on Wednesday 15th April. Guillaume will present "SRSF1-dependent RNA nuclear export gene inhibition therapies for the treatment of C9ORF72-linked ALS/FTD and other neurodegenerative diseases" in Parallel Session 5 on Thursday 16th April.
If you would like to meet with us to discuss how we can support you with AAV manufacturing, translation of your therapy from bench to clinical trial or how we address the skills gap, we look forward to speaking with you in Newcastle.